協調DNAメチルトランスフェラーゼ3Aとメチルトランスフェラーゼ型7Aの活動により,ディスクイジン領域受容体1のシグナル伝達により,腫瘍の微環境が再プログラムされます
Zhengyang Bai1, Dan Yang1, Jiayi Li2
1The First Clinical Medical School of Ningxia Medical University (General Hospital of Ningxia Medical University), Yinchuan 750004, China.
Cancer biology & medicine
|February 17, 2026
まとめ
エピジェネティックレギュレータであるDNMT3AとMETTL7Aは,DDR1/STAT3/CXCL5軸を制御することで乳がんの再発を誘発し,免疫逃避と腫瘍の成長を促します. DDR1を静音化することで,これらの効果は逆転し,新たな治療目標を提供した.
科学分野:
- 分子腫瘍学 分子腫瘍学
- エピジェネティクス エピジェネティクス
- がん免疫学 がん免疫学
背景:
- 乳がんの再発は,患者の生存に重大な影響を及ぼします.
- 腫瘍の微環境を調節するT細胞 (Tregs) は,免疫逃避と転移を促進する.
- エピジェネティックレギュレータであるDNMT3AとMETTL7Aは,がんの進行に関与しています.
研究 の 目的:
- DNMT3AとMETTL7Aが,DDR1/STAT3/CXCL5軸経由でTreg浸透を調節する方法を調査する.
- 乳がんの再発と予後におけるこの軸の役割を決定する.
主な方法:
- RNAの配列解析により,異なった発現する遺伝子を特定した.
- 機械学習アルゴリズム (LASSO,SVM-RFE,ElasticNet) はDDR1を重要な遺伝子として特定しました.
- 検証には,RT-qPCR,ウェスタン・ブラット,メチレーション特異PCR,MeRIP-qPCR,Co-IP,機能分析,そして異種移植モデルが含まれていました.
主要な成果:
- DNMT3AはDNAメチル化を介してDDR1をアップレギュレーションし,METTL7Aはm6A修飾を介してDDR1mRNAの安定性を強化した.
- 同調節により,DDR1/STAT3/CXCL5軸が活性化され,がん細胞の増殖,移動,侵入が増加した.
- CXCL5の分泌は,Tregの浸透と腫瘍の成長を活体内で促進した;DDR1の静止は,これらの効果を逆転させた.
結論:
- DNMT3AとMETTL7AはDNA/m6Aメチル化を介して協力してDDR1を調節し,Treg媒介の免疫抑制と再発を引き起こす.
- DDR1/STAT3/CXCL5軸は,乳がんの再発において重要な役割を果たしています.
- これらの発見は,乳がんの予後と治療のための新しい洞察と潜在的な治療目標を提供します.
関連する概念動画
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Master Transcription Regulators
7.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Epigenetic Regulation
3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.9K
Epigenetic Regulation
34.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.0K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K


